How And When To Leverage Integrated Evidence Plans (Part 1)
Key points:
- Dynamic World: Explore integrated evidence plans (IEPs)
- Pharmaceutical Strategies: Align across functions and geographies
- Product Lifecycle: Support throughout the lifecycle
- Complexities and Significance: Dive into IEPs’ importance
- Jenny Devenport: Guest with medical affairs experience
- Minimizing Duplication: Crucial for efficient planning
- Stakeholder Needs: Cater to various requirements
- Statisticians’ Role: Shape and Influence IEPs
We dive into the essential role these plans play in the pharmaceutical industry and how statisticians can significantly contribute to their success.
Tune in to gain valuable insights and practical knowledge that will elevate your understanding and application of IEPs. Share this episode with your colleagues who will benefit from this discussion. Listen now and join the conversation!
Comments
New comment